Abiopharma

New Form 4 - BRISTOL MYERS SQUIBB CO Filed: 2025-07-01 AccNo: 0000014272-25-000117 Size: 176 KB

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021814 Size: 5 KB

New Form 4 - ABBOTT LABORATORIES Filed: 2025-07-01 AccNo: 0001415889-25-018736 Size: 9 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-07-01 AccNo: 0000919574-25-003890 Size: 15 KB

New Form 8-K - Akari Therapeutics Plc Filed: 2025-07-01 AccNo: 0000950170-25-092350 Size: 331 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021808 Size: 5 KB

New Form 8-K - U S PHYSICAL THERAPY INC /NV Filed: 2025-07-01 AccNo: 0000885978-25-000032 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021803 Size: 5 KB

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

New Form 4 - Kezar Life Sciences, Inc. Filed: 2025-07-01 AccNo: 0001415889-25-018733 Size: 5 KB

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021801 Size: 5 KB

New Form 4 - ABBOTT LABORATORIES Filed: 2025-07-01 AccNo: 0001415889-25-018731 Size: 9 KB

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021797 Size: 5 KB

New Form 8-K - PERRIGO Co plc Filed: 2025-07-01 AccNo: 0001193125-25-154126 Size: 239 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - OMEROS CORP Filed: 2025-07-01 AccNo: 0001437749-25-021795 Size: 5 KB